ArticleBMC pulmonary medicine2026
The systemic immune-inflammation index combined with the platelet-to-lymphocyte ratio demonstrates notable potential as a prognostic tool for older adults with pneumonia caused by influenza A virus infection: a retrospective cohort study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe clinical course of influenza A virus (IAV) pneumonia in elderly patients is highly variable and strongly influenced by immunosenescence and dysregulated inflammation. Despite the prognostic relevance of inflammatory markers, reliably stratifying high-risk patients remains challenging. We investigated the combined potential of the systemic immune-inflammation index (SII) and the platelet-to-lymphocyte ratio (PLR) as a novel, accessible composite prognostic tool for this susceptible population.
methodsA retrospective analysis was conducted on 160 patients aged ≥ 65 years with IAVP, who were divided into favorable prognosis (CURB-65 < 3, n = 71) and poor prognosis (CURB-65 ≥ 3, n = 89) groups based on their CURB-65 scores.
resultsThe poor prognosis group exhibited significantly higher levels of white blood cells, neutrophils, C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), blood urea nitrogen (BUN), creatinine (Cr), PLR, and SII, as well as lower levels of prealbumin, albumin, total protein, and lymphocyte counts (all P < 0.05).
conclusionBoth PLR and SII are positively correlated with disease severity and serve as independent prognostic indicators in elderly IAVP patients. Their combination enhances the accuracy and generalizability of clinical risk stratification models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.